|
1
|
Ota I, Okamoto N, Yane K, Takahashi A,
Masui T, Hosoi H and Ohnishi T: Therapeutic strategies for head and
neck cancer based on p53 status. Exp Ther Med. 3:585–591.
2012.PubMed/NCBI
|
|
2
|
Ozdek A, Sarac S, Akyol MU, Unal OF and
Sungur A: Histopathological predictors of occult lymph node
metastases in supraglottic squamous cell carcinomas. Eur Arch
Otorhinolaryngol. 257:389–392. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang L, Chen C, Li F, Hua Q, Chen S, Xiao
B, Dai M, Li M, Zheng A, Yu D, et al: Down-regulation of neutrophil
gelatinase-associated lipocalin in head and neck squamous cell
carcinoma correlated with tumorigenesis, not with metastasis. Int J
Clin Exp Pathol. 8:8857–8868. 2015.PubMed/NCBI
|
|
5
|
Koole K, van Kempen PM, Swartz JE, Peeters
T, van Diest PJ, Koole R, van Es RJ and Willems SM: Fibroblast
growth factor receptor 3 protein is overexpressed in oral and
oropharyngeal squamous cell carcinoma. Cancer Med. 5:275–284. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haupt H and Baudner S: Isolation and
characterization of an unknown, leucine-rich
3.1-S-alpha2-glycoprotein from human serum (author's transl). Hoppe
Seylers Z Physiol Chem. 358:639–646. 1977.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kobe B and Kajava AV: The leucine-rich
repeat as a protein recognition motif. Curr Opin Struct Biol.
11:725–732. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Buchanan SG and Gay NJ: Structural and
functional diversity in the leucine-rich repeat family of proteins.
Prog Biophys Mol Biol. 65:1–44. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Serada S, Fujimoto M, Terabe F, Iijima H,
Shinzaki S, Matsuzaki S, Ohkawara T, Nezu R, Nakajima S, Kobayashi
T, et al: Serum leucine-rich alpha-2 glycoprotein is a disease
activity biomarker in ulcerative colitis. Inflamm Bowel Dis.
18:2169–2179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kharbanda AB, Rai AJ, Cosme Y, Liu K and
Dayan PS: Novel serum and urine markers for pediatric appendicitis.
Acad Emerg Med. 19:56–62. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Serada S, Fujimoto M, Ogata A, Terabe F,
Hirano T, Iijima H, Shinzaki S, Nishikawa T, Ohkawara T, Iwahori K,
et al: iTRAQ-based proteomic identification of leucine-rich alpha-2
glycoprotein as a novel inflammatory biomarker in autoimmune
diseases. Ann Rheum Dis. 69:770–774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Abraham S, McKenzie JA, Jeffs N,
Swire M, Tripathi VB, Luhmann UF, Lange CA, Zhai Z, Arthur HM, et
al: LRG1 promotes angiogenesis by modulating endothelial TGF-β
signalling. Nature. 499:306–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He X, Wang Y, Zhang W, Li H, Luo R, Zhou
Y, Li C, Liao M, Huang H, Lv X, et al: Screening differential
expression of serum proteins in AFP-negative HBV-related
hepatocellular carcinoma using iTRAQ -MALDI-MS/MS. Neoplasma. Sep
20–2013.(Epub ahead of print). doi: 10.4149/neo_2014_001.
|
|
14
|
Wu J, Xie X, Nie S, Buckanovich RJ and
Lubman DM: Altered expression of sialylated glycoproteins in
ovarian cancer sera using lectin-based ELISA assay and quantitative
glycoproteomics analysis. J Proteome Res. 12:3342–3352. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wen SY, Zhang LN, Yang XM, Zhang YL, Ma L,
Ge QL, Jiang SH, Zhu XL, Xu W, Ding WJ, et al: LRG1 is an
independent prognostic factor for endometrial carcinoma. Tumour
Biol. 35:7125–7133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Uen YH, Lin KY, Sun DP, Liao CC, Hsieh MS,
Huang YK, Chen YW, Huang PH, Chen WJ, Tai CC, et al: Comparative
proteomics, network analysis and post-translational modification
identification reveal differential profiles of plasma Con A-bound
glycoprotein biomarkers in gastric cancer. J Proteomics.
83:197–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu RS, Yu CS, Liu KC, Huang HY, Ip SW, Lin
JP, Chueh FS, Yang JS and Chung JG: Citosol (thiamylal sodium)
triggers apoptosis and affects gene expressions of murine leukemia
RAW 264.7 cells. Hum Exp Toxicol. 31:771–779. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ladd JJ, Busald T, Johnson MM, Zhang Q,
Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z,
et al: Increased plasma levels of the APC-interacting protein
MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer
in women. Cancer Prev Res. 5:655–664. 2012. View Article : Google Scholar
|
|
19
|
Kakisaka T, Kondo T, Okano T, Fujii K,
Honda K, Endo M, Tsuchida A, Aoki T, Itoi T, Moriyasu F, et al:
Plasma proteomics of pancreatic cancer patients by
multi-dimensional liquid chromatography and two-dimensional
difference gel electrophoresis (2D-DIGE): Up-regulation of
leucine-rich alpha-2-glycoprotein in pancreatic cancer. J
Chromatogr B Analyt Technol Biomed Life Sci. 852:257–267. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lindén M, Segersten U, Runeson M, Wester
K, Busch C, Pettersson U, Lind SB and Malmström PU: Tumour
expression of bladder cancer-associated urinary proteins. BJU Int.
112:407–415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jemal A, Thun MJ, Ries LA, Howe HL, Weir
HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, et al: Annual
report to the nation on the status of cancer, 1975–2005, featuring
trends in lung cancer, tobacco use, and tobacco control. J Natl
Cancer Inst. 100:1672–1694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu J, Yin H, Zhu J, Buckanovich RJ, Thorpe
JD, Dai J, Urban N and Lubman DM: Validation of LRG1 as a potential
biomarker for detection of epithelial ovarian cancer by a blinded
study. PLoS One. 10:e01211122015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Zhang Y, Qiu F and Qiu Z: Proteomic
identification of exosomal LRG1: A potential urinary biomarker for
detecting NSCLC. Electrophoresis. 32:1976–1983. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lynch J, Meehan MH, Crean J, Copeland J,
Stallings RL and Bray IM: Metastasis suppressor microRNA-335
targets the formin family of actin nucleators. PLoS One.
8:e784282013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lynch J, Fay J, Meehan M, Bryan K, Watters
KM, Murphy DM and Stallings RL: MiRNA-335 suppresses neuroblastoma
cell invasiveness by direct targeting of multiple genes from the
non-canonical TGF-β signalling pathway. Carcinogenesis. 33:976–985.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhong D, He G, Zhao S, Li J, Lang Y, Ye W,
Li Y, Jiang C and Li X: LRG1 modulates invasion and migration of
glioma cell lines through TGF-β signaling pathway. Acta Histochem.
117:551–558. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Luo Q, Wang N, Hu F, Jin H, Ge T,
Wang C and Qin W: LRG1 suppresses the migration and invasion of
hepatocellular carcinoma cells. Med Oncol. 32:1462015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takemoto N, Serada S, Fujimoto M, Honda H,
Ohkawara T, Takahashi T, Nomura S, Inohara H and Naka T:
Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth
suppression in the Lewis lung carcinoma cell lines. Oncotarget.
6:11009–11022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schonberg DL, Lubelski D, Miller TE and
Rich JN: Brain tumor stem cells: Molecular characteristics and
their impact on therapy. Mol Aspects Med. 39:82–101. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cavazza A, Corradini C, Marini M, Roda LG
and Valenti A: Capillary electrophoresis coupled with mass
spectrometry for the evaluation of substance P enzymatic
degradation by SaOS-2 human osteosarcoma. J Chromatogr B Analyt
Technol Biomed Life Sci. 879:2501–2506. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sulzbacher I, Birner P, Dominkus M,
Pichlhofer B and Mazal PR: Expression of platelet-derived growth
factor-alpha receptor in human osteosarcoma is not a predictor of
outcome. Pathology. 42:664–668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhong D, Zhao S, He G, Li J, Lang Y, Ye W,
Li Y, Jiang C and Li X: Stable knockdown of LRG1 by RNA
interference inhibits growth and promotes apoptosis of glioblastoma
cells in vitro and in vivo. Tumour Biol. 36:4271–4278. 2015.
View Article : Google Scholar : PubMed/NCBI
|
